GoodRx Holdings, Inc. (GDRX) Deferred Tax Assets, Valuation Allowance USD 2019 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
GoodRx Holdings, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from 2019 to 2023.
  • GoodRx Holdings, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $7.82 M, a 86.3% decline year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $7.82 M -$49.3 M -86.3% Dec 31, 2023 10-K 2024-02-29
Q4 2022 $57.1 M +$4.44 M +8.42% Dec 31, 2022 10-K 2024-02-29
Q4 2021 $52.7 M +$52.4 M +19556% Dec 31, 2021 10-K 2023-03-01
Q4 2020 $268 K -$293 K -52.2% Dec 31, 2020 10-K 2022-03-01
Q4 2019 $561 K Dec 31, 2019 10-K 2021-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.